KA
Kairos Pharma, Ltd. (KAPA)
AMEX·Healthcare·Biotechnology
$0.59
-1.50%
Mkt Cap $12.83M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.02 | -$0.07 | -264.08% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.10 | -$0.07 | +30.00% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.06 | -$0.08 | -33.33% | — | — |
| Q2 2025 Apr 15, 2025 | — | — | — | -$0.05 | -$0.08 | -60.00% | — | — |
| Q1 2025 Feb 26, 2025 | — | — | — | -$0.06 | -$0.09 | -43.82% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.02 | -$0.10 | -400.00% | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | — | -$0.02 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.03 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.11 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.03 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.02 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.01 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.02 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.02 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.04 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.02 | — | — | — |